Pacira Appoints CMO
This article was originally published in Scrip
Executive Summary
Parsippany, New Jersey-based Pacira Pharmaceuticals, Inc. has named Dr. James B. Jones senior vice-president and chief medical officer. Most recently Jones was vice-president at The Medicines Company. At Pacira, he will be primarily responsible for overseeing and guiding the company's clinical research and development efforts for the expanded uses of Exparel (bupivacaine liposome injectable suspension) and the DepoFoam pipeline of products. Jones replaces former CMO Dr. Gary Patou, who will remain with the company as a clinical consultant.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.